You are here: Industry Insights > Chloroquine

News List

Common Malaria Treatments David Orchard-Webb
December 01, 2023
Malaria is a mosquito-borne parasitic disease that causes high fever, severe chills, and sweating.
India’s Pharmaceutical Industry Disruption Impacts Africa and the World Shem Oirere
August 06, 2021
India is one of the top global pharmaceutical producing markets that a large share of the global healthcare systems relies on for supply of drug formulations and biologicals at least until COVID-19 pandemic struck.
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems fda
July 08, 2020
A summary of the FDA review of safety issues with the use of hydroxychloroquine and chloroquine to treat hospitalized patients with COVID-19 is now available.
US FDA warns against co-administration of remdesivir and chloroquine or HCQ expresspharma
June 17, 2020
The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19 treatment.
US FDA revokes EUA for chloroquine and hydroxychloroquine expresspharma
June 17, 2020
The known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorised use, said the drug regulator.
FDA revokes authorisation for anti-malarials to treat Covid-19 pharmaceutical-technology
June 16, 2020
The US Food and Drug Administration (FDA) has revoked the emergency use authorisation (EUA) for anti-malarials, chloroquine phosphate and hydroxychloroquine sulfate, to treat some hospitalised Covid-19 patients.
First do no harm - researchers urge halt in prescribing hydroxycholoroquine for COVID-19 worldpharmanews
June 04, 2020
The sacred oath taken by physicians during graduation from medical school to "First do no harm," the first words of the Hippocratic Oath, provides a strong impetus for a commentary just published in The American Journal of Medicine.
First UK healthcare worker to enrol in COVID-19 prevention trial pharmatimes
May 21, 2020
The first UK frontline NHS worker will today enrol in a new study designed to test the potential of hydroxychloroquine to prevent infection with novel coronavirus.
Certara and DMTC announce research collaboration to study preventative use of chloroquine in health pharmaceutical-business-review
May 12, 2020
Certara, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a research collaboration.
FDA COVID-19 Update contractpharma
April 28, 2020
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine.

Previous page 1 2 Next page